|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.72 USD | -5.07% |
|
+12.77% | +94.07% |
| Jun. 23 | Needham Raises CorMedix's Price Target to $20 from $15, Keeps Buy Rating | MT |
| Jun. 23 | CorMedix Expands DefenCath Rollout; Raises Q2 Sales Guidance | MT |
| Capitalization | 1.12B 973M 913M 832M 1.54B 97.26B 1.74B 10.82B 4.16B 44.62B 4.21B 4.12B 164B | P/E ratio 2025 * |
20.6x | P/E ratio 2026 * | 11.9x |
|---|---|---|---|---|---|
| Enterprise value | 976M 846M 793M 723M 1.34B 84.53B 1.52B 9.4B 3.62B 38.78B 3.66B 3.58B 143B | EV / Sales 2025 * |
6.74x | EV / Sales 2026 * | 4.08x |
| Free-Float |
99.03% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: CorMedix Inc.
More recommendations
More press releases
| 1 day | -3.14% | ||
| 1 week | +15.35% | ||
| Current month | +32.45% | ||
| 1 month | +28.33% | ||
| 3 months | +49.30% | ||
| 6 months | +93.04% | ||
| Current year | +98.52% |
| 1 week | 13.37 |  | 17.43 |
| 1 month | 11.88 | | 17.43 |
| Current year | 5.6 | | 17.43 |
| 1 year | 3.61 | | 17.43 |
| 3 years | 2.57 | | 17.43 |
| 5 years | 2.57 | | 18.8 |
| 10 years | 0.86 | | 26.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Todisco
CEO | Chief Executive Officer | 49 | 2022-05-09 |
Mathew David
CEO | Chief Executive Officer | 48 | 2021-10-03 |
Tushar Mukherjee
CTO | Chief Tech/Sci/R&D Officer | - | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Janet Dillione
BRD | Director/Board Member | 66 | 2015-08-05 |
Myron Kaplan
CHM | Chairman | 80 | 2017-08-02 |
Steven Lefkowitz
BRD | Director/Board Member | 69 | 2011-08-15 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 0% | 293,477 M€ | -1.79% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.14% | +15.35% | +278.35% | +366.09% | 1.12B | ||
| +2.15% | -0.36% | -33.13% | -32.22% | 54.87B | ||
| +0.16% | -0.48% | -7.78% | -17.88% | 8.87B | ||
| +1.98% | +1.66% | +3.71% | +15.12% | 6.51B | ||
| +1.58% | -3.39% | +32.35% | +107.38% | 5.45B | ||
| +2.20% | +1.09% | +22.24% | +32.52% | 5.16B | ||
| +0.55% | -10.51% | +54.40% | -6.07% | 3.22B | ||
| -1.58% | -2.83% | +16.72% | +10.60% | 2B | ||
| +1.82% | -1.48% | -0.28% | +16.41% | 1.95B | ||
| +1.96% | -1.13% | -57.79% | -13.33% | 1.73B | ||
| Average | +0.80% | +0.60% | +30.88% | +47.86% | 9.09B | |
| Weighted average by Cap. | +1.87% | -2.85% | -12.66% | -7.19% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 145M 126M 118M 107M 199M 12.54B 225M 1.4B 537M 5.76B 544M 532M 21.2B | 213M 185M 173M 158M 293M 18.45B 331M 2.05B 789M 8.47B 800M 783M 31.19B |
| Net income | 56.05M 48.56M 45.54M 41.51M 76.96M 4.85B 87.06M 540M 208M 2.23B 210M 206M 8.2B | 103M 89.24M 83.7M 76.29M 141M 8.92B 160M 992M 382M 4.09B 386M 378M 15.08B |
| Net Debt | -147M -127M -119M -109M -202M -12.73B -228M -1.42B -545M -5.84B -552M -540M -21.52B | -254M -220M -206M -188M -348M -21.95B -394M -2.44B -939M -10.07B -951M -931M -37.11B |
More financial data
* Estimated data
Employees
65
Sector
Pharmaceuticals
Calendar
09:00am
- Annual General Meeting
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-06-24 | 15.72 $ | -5.07% | 2,520,132 |
| 25-06-23 | 16.56 $ | +21.68% | 7,091,502 |
| 25-06-20 | 13.61 $ | +0.22% | 1,678,393 |
| 25-06-18 | 13.58 $ | -2.58% | 1,313,135 |
| 25-06-17 | 13.94 $ | -2.79% | 1,135,064 |
Delayed Quote Nasdaq, June 24, 2025 at 01:28 pm EDT
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
16.56USD
Average target price
17.50USD
Spread / Average Target
+5.68%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CRMD Stock
Select your edition
All financial news and data tailored to specific country editions
